Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Enterprise Value (2019 - 2025)

Historic Enterprise Value for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to -$37.1 million.

  • Eton Pharmaceuticals' Enterprise Value fell 8321.41% to -$37.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.1 million, marking a year-over-year decrease of 8321.41%. This contributed to the annual value of -$14.9 million for FY2024, which is 3016.64% up from last year.
  • Eton Pharmaceuticals' Enterprise Value amounted to -$37.1 million in Q3 2025, which was down 8321.41% from -$25.4 million recorded in Q2 2025.
  • Eton Pharmaceuticals' 5-year Enterprise Value high stood at -$13.4 million for Q3 2022, and its period low was -$37.1 million during Q3 2025.
  • Moreover, its 5-year median value for Enterprise Value was -$17.7 million (2024), whereas its average is -$20.0 million.
  • Per our database at Business Quant, Eton Pharmaceuticals' Enterprise Value tumbled by 20972.45% in 2021 and then skyrocketed by 4108.94% in 2022.
  • Eton Pharmaceuticals' Enterprise Value (Quarter) stood at -$14.4 million in 2021, then fell by 13.18% to -$16.3 million in 2022, then crashed by 31.17% to -$21.4 million in 2023, then surged by 30.17% to -$14.9 million in 2024, then plummeted by 148.53% to -$37.1 million in 2025.
  • Its Enterprise Value was -$37.1 million in Q3 2025, compared to -$25.4 million in Q2 2025 and -$17.4 million in Q1 2025.